Literature DB >> 11551946

Activation of p21(WAF1/Cip1) transcription through Sp1 sites by histone deacetylase inhibitor apicidin: involvement of protein kinase C.

J W Han1, S H Ahn, Y K Kim, G U Bae, J W Yoon, S Hong, H Y Lee, Y W Lee, H W Lee.   

Abstract

We previously reported that apicidin, a novel histone deacetylase inhibitor, inhibited the proliferation of tumor cells via induction of p21(WAF1/Cip1). In this study, we determined the molecular mechanisms by which apicidin induced the p21(WAF1/Cip1) gene expression in HeLa cells. Apicidin induced p21(WAF1/Cip1) mRNA independent of the de novo protein synthesis and activated the p21(WAF1/Cip1) promoter through Sp1-3 site located at -82 and -77 relative to the transcription start site. This transcriptional activation appears to be mediated by protein kinase C (PKC), because calphostin C, a PKC inhibitor, significantly attenuated the activation of p21(WAF1/Cip1) promoter via Sp1 sites, which was accompanied by a marked suppression of p21(WAF1/Cip1) mRNA and protein expression induced by apicidin. Consistent with the transcriptional activation of p21(WAF1/Cip1) promoter by apicidin, apicidin treatment led to the translocation of PKCepsilon from cytosolic to particulate fraction, which was reversed by pretreatment with calphostin C, indicating the involvement of PKC in the transcriptional activation of p21(WAF1/Cip1) via Sp1 sites by apicidin. However, the PKC-mediated transcriptional activation of p21(WAF1/Cip1) by apicidin appears to be independent of the histone hyperacetylation, because apicidin-induced histone hyperacetylation was not affected by calphostin C. Furthermore, a PKC activator, phorbol 12,13-dibutyrate, alone induced the transcriptional activation of p21(WAF1/Cip1) promoter, p21(WAF1/Cip1) mRNA, and protein expression without induction of the histone hyperacetylation, suggesting that the transcriptional activation of p21(WAF1/Cip1) by apicidin might have been mediated by a mechanism other than chromatin remodeling through the histone hyperacetylation. Taken together, these results suggest that the PKC signaling pathway plays a pivotal role in the transcriptional activation of the p21(WAF1/Cip1) gene by apicidin.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11551946     DOI: 10.1074/jbc.M106688200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  Phosphatidylinositol 3-kinase/protein kinase Czeta-induced phosphorylation of Sp1 and p107 repressor release have a critical role in histone deacetylase inhibitor-mediated derepression [corrected] of transcription of the luteinizing hormone receptor gene.

Authors:  Ying Zhang; Mingjuan Liao; Maria L Dufau
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

2.  Nonsteroidal anti-inflammatory drug-activated gene (NAG-1/GDF15) expression is increased by the histone deacetylase inhibitor trichostatin A.

Authors:  Hiroki Yoshioka; Hideki Kamitani; Takashi Watanabe; Thomas E Eling
Journal:  J Biol Chem       Date:  2008-09-17       Impact factor: 5.157

3.  A novel function of RNAs arising from the long terminal repeat of human endogenous retrovirus 9 in cell cycle arrest.

Authors:  Lai Xu; Abdel G Elkahloun; Fabio Candotti; Andrzej Grajkowski; Serge L Beaucage; Emanuel F Petricoin; Valerie Calvert; Hartmut Juhl; Frederick Mills; Karen Mason; Neal Shastri; Josh Chik; Cynthia Xu; Amy S Rosenberg
Journal:  J Virol       Date:  2012-10-24       Impact factor: 5.103

4.  Histone hyperacetylation up-regulates protein kinase Cδ in dopaminergic neurons to induce cell death: relevance to epigenetic mechanisms of neurodegeneration in Parkinson disease.

Authors:  Huajun Jin; Arthi Kanthasamy; Dilshan S Harischandra; Naveen Kondru; Anamitra Ghosh; Nikhil Panicker; Vellareddy Anantharam; Ajay Rana; Anumantha G Kanthasamy
Journal:  J Biol Chem       Date:  2014-10-23       Impact factor: 5.157

Review 5.  Histone acetylation in reproductive organs: Significance of histone deacetylase inhibitors in gene transcription.

Authors:  Hiroshi Uchida; Tetsuo Maruyama; Toru Arase; Masanori Ono; Takashi Nagashima; Hirotaka Masuda; Hironori Asada; Yasunori Yoshimura
Journal:  Reprod Med Biol       Date:  2005-05-03

6.  Preclinical validation of AR42, a novel histone deacetylase inhibitor, as treatment for vestibular schwannomas.

Authors:  Abraham Jacob; Janet Oblinger; Matthew L Bush; Victoria Brendel; Griffin Santarelli; Abhik R Chaudhury; Samuel Kulp; Krista M D La Perle; Ching-Shih Chen; Long-Sheng Chang; D Bradley Welling
Journal:  Laryngoscope       Date:  2011-11-22       Impact factor: 3.325

Review 7.  Histone deacetylases (HDACs): characterization of the classical HDAC family.

Authors:  Annemieke J M de Ruijter; Albert H van Gennip; Huib N Caron; Stephan Kemp; André B P van Kuilenburg
Journal:  Biochem J       Date:  2003-03-15       Impact factor: 3.857

8.  The tumor suppressor p53 and histone deacetylase 1 are antagonistic regulators of the cyclin-dependent kinase inhibitor p21/WAF1/CIP1 gene.

Authors:  Gerda Lagger; Angelika Doetzlhofer; Bernd Schuettengruber; Eva Haidweger; Elisabeth Simboeck; Julia Tischler; Susanna Chiocca; Guntram Suske; Hans Rotheneder; Erhard Wintersberger; Christian Seiser
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

9.  Phosphorylation of histone H3 by protein kinase C signaling plays a critical role in the regulation of the developmentally important TBX2 gene.

Authors:  Huajian Teng; Reyna Deeya Ballim; Shaheen Mowla; Sharon Prince
Journal:  J Biol Chem       Date:  2009-07-24       Impact factor: 5.157

10.  Butyrate mediates decrease of histone acetylation centered on transcription start sites and down-regulation of associated genes.

Authors:  Alvaro Rada-Iglesias; Stefan Enroth; Adam Ameur; Christoph M Koch; Gayle K Clelland; Patricia Respuela-Alonso; Sarah Wilcox; Oliver M Dovey; Peter D Ellis; Cordelia F Langford; Ian Dunham; Jan Komorowski; Claes Wadelius
Journal:  Genome Res       Date:  2007-06       Impact factor: 9.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.